Frazier William 4

What Happened

• William Frazier, Chief Medical Officer and a director of Viemed Healthcare, received equity awards on January 19, 2026. The filing shows grants of 11,690 restricted stock units (RSUs) and 2,922 phantom share units, each granted with a $0 purchase price (derivative awards, not cash purchases).
• RSUs represent a contingent right to receive one common share on vesting; phantom share units represent a right to receive cash equal to the share value on the vesting date. These awards do not represent an immediate sale or open-market purchase by the insider.

Key Details

• Transaction date: January 19, 2026; Form 4 filed January 21, 2026 (filed within the usual two-business-day window).
• Award amounts: 11,690 RSUs and 2,922 phantom share units; grant price shown as $0 (typical for awards).
• Vesting: Both award types vest in three equal annual installments beginning on the first anniversary of the grant (per filing footnotes).
• Shares owned after transaction: Not specified in the provided filing summary.
• Notes: RSUs convert to ordinary shares on vesting (footnote F1/F2). Phantom units are cash-settled based on the company share price at vesting (footnote F3/F4). Transaction code A = Award/Grant.

Context

• These are compensation awards (retention/long-term incentive), not open-market buys or sales; they indicate a standard equity grant rather than immediate insider buying or selling.
• RSUs and phantom units are common executive compensation tools; RSUs increase eventual equity ownership if they vest, while phantom units pay cash tied to share value.